Skip to content

Medical emergency? What to do

States petition US FDA on generic insulin, hormone

3-RXPublished August 5, 20062 min read

Key points

  • Four governors, looking to ease drug costs under state programs, petitioned the U.S.
  • In their petition, the governors joined other critics in accusing the agency of dragging its feet.
  • Kathleen Sebelius of Kansas and Jim Doyle of Wisconsin joined Republicans Tim Pawlenty of Minnesota and James Douglas of Vermont in signing the petition.
  • Both insulin, used to treat diabetics, and growth hormone, used to treat growth disorder, are protein-based drugs known as biologics.

Four governors, looking to ease drug costs under state programs, petitioned the U.S. Food and Drug Administration on Thursday to provide guidelines for generic versions of insulin and human growth hormone.

The FDA has been developing regulatory advice for companies who want to make cheaper copycat versions of the injectable drugs since 2001, but recently delayed issuing final guidelines.

In their petition, the governors joined other critics in accusing the agency of dragging its feet.

"We have been informed that there are no scientific reasons for delaying the issuance of the guidance documents FDA already has drafted," the bipartisan group of governors wrote the FDA.

Democratic Govs. Kathleen Sebelius of Kansas and Jim Doyle of Wisconsin joined Republicans Tim Pawlenty of Minnesota and James Douglas of Vermont in signing the petition.

"There is no legal or regulatory obstacle to the immediate issuance of these guidance documents," they added.

Both insulin, used to treat diabetics, and growth hormone, used to treat growth disorder, are protein-based drugs known as biologics.

With a growing number of diabetics in the Unites States and tightening state budgets, the governors are eager for cheaper insulin alternatives.

"The FDA's delay in informing manufacturers of the requirements for obtaining approval of therapeutically equivalent versions of insulin and HGH has cost the states and other health-care providers hundreds of millions of dollars," the petition said.

About 7 percent of Americans, or nearly 21 million people, have diabetes, according to the National Institutes of Health. Growth disorders are more difficult to measure. Not all those diagnosed with either condition are treated.

Many states pay for prescription drugs through the joint federal-state Medicaid program for the poor as well as special insurance programs for children.

Because insulin and growth hormone were approved decades ago as regular drugs, supporters argue the FDA has the legal authority to approve generic versions.

The issue of cheaper alternatives to other biological drugs remains in limbo. Brand name companies say biologics are too complicated to copy.

In May, the agency approved a generic version of human growth hormone made by Novartis AG's Sandoz unit called Omnitrope but said the decision did not set any precedent for other biologics.

The FDA did not have immediate comment on the petition.

The Generic Pharmaceutical Association supported the governors' move as a way to force the FDA's hand. The Biotechnology Industry Organization, which represents brand name makers, did not have immediate comment.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Experimental drug shrinks cancer tumors

An experimental cancer drug successfully shrank tumors in patients with different kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists said the research was…

4 min read

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.